DAFNA Capital Management LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$2,646,000
+67.5%
438,8840.0%0.91%
+52.9%
Q3 2019$1,580,000
-2.5%
438,884
-27.4%
0.59%
-2.5%
Q2 2019$1,621,000
-11.9%
604,884
-2.6%
0.61%
-23.2%
Q1 2019$1,839,000
+83.5%
621,182
-1.4%
0.79%
+59.2%
Q4 2018$1,002,000
-67.9%
630,182
-25.7%
0.50%
-61.1%
Q3 2018$3,119,000
+16.3%
847,636
-10.6%
1.28%
+2.0%
Q2 2018$2,682,000
-16.7%
947,636
+9.1%
1.26%
-19.8%
Q1 2018$3,221,000
+17.9%
868,272
-8.4%
1.57%
+6.5%
Q4 2017$2,731,000
-15.3%
948,272
+32.0%
1.47%
-26.5%
Q3 2017$3,225,000
+163.7%
718,272
+169.5%
2.00%
+129.3%
Q2 2017$1,223,000
+47.9%
266,500
+35.6%
0.87%
+24.9%
Q1 2017$827,000
+1.8%
196,5000.0%0.70%
-2.0%
Q4 2016$812,000
-46.3%
196,500
+5.4%
0.71%
-32.2%
Q3 2016$1,511,000
-18.1%
186,500
-21.1%
1.05%
-28.0%
Q2 2016$1,845,000
+1.0%
236,5000.0%1.46%
-7.2%
Q1 2016$1,826,000
-28.4%
236,5000.0%1.58%
-30.8%
Q4 2015$2,552,000
-23.1%
236,500
-50.8%
2.28%
-30.9%
Q3 2015$3,319,000
-22.0%
480,3000.0%3.29%
-8.5%
Q2 2015$4,255,000
+78.6%
480,300
+98.8%
3.60%
+96.8%
Q1 2015$2,382,000
-1.5%
241,600
+22.3%
1.83%
-4.4%
Q4 2014$2,419,000
+834.0%
197,500
+659.6%
1.91%
+633.3%
Q3 2014$259,000
-29.6%
26,000
-78.7%
0.26%
-35.1%
Q3 2013$368,000
-63.1%
121,8000.0%0.40%
-72.4%
Q2 2013$996,000121,8001.46%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders